share_log

Private Companies in SEP Analytical (Shanghai) Co., Ltd. (SZSE:301228) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 24% Last Week

Private Companies in SEP Analytical (Shanghai) Co., Ltd. (SZSE:301228) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 24% Last Week

上海證券交易所上市的 SEP Analytical ( 上海 ) 有限公司 ( SZSE:301228 ) 的私營公司是其最大的賭注,他們的投資回報豐厚,上週股票漲幅達 24%。
Simply Wall St ·  2024/12/20 17:08

Key Insights

關鍵洞察

  • Significant control over SEP Analytical (Shanghai) by private companies implies that the general public has more power to influence management and governance-related decisions
  • A total of 2 investors have a majority stake in the company with 52% ownership
  • Institutional ownership in SEP Analytical (Shanghai) is 12%
  • 私營公司對SEP Analytical (上海)的重大控制意味着公衆在管理和治理相關決策中擁有更多的影響力
  • 共有2位投資者擁有該公司的多數股份,擁有52%的股份。
  • 在SEP Analytical (上海)中的機構持有比例爲12%

If you want to know who really controls SEP Analytical (Shanghai) Co., Ltd. (SZSE:301228), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are private companies with 59% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果你想知道誰真正控制了SEP Analytical (上海)有限公司(SZSE:301228),那麼你需要查看其股份登記的構成。而持有最大份額的群體是持有59%股份的私營公司。換句話說,這個群體從他們對公司的投資中獲益最多(或損失最多)。

As a result, private companies were the biggest beneficiaries of last week's 24% gain.

因此,私營公司是上週24%上漲的最大受益者。

Let's take a closer look to see what the different types of shareholders can tell us about SEP Analytical (Shanghai).

讓我們仔細看看不同類型的股東能告訴我們關於SEP Analytical(上海)什麼。

big
SZSE:301228 Ownership Breakdown December 20th 2024
深交所:301228 股權結構 2024年12月20日

What Does The Institutional Ownership Tell Us About SEP Analytical (Shanghai)?

機構持股告訴我們關於SEP Analytical(上海)什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。

We can see that SEP Analytical (Shanghai) does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see SEP Analytical (Shanghai)'s historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到SEP Analytical(上海)確實有機構投資者,他們持有公司股票的相當一部分。這在專業投資者中暗示了一定的可信度。但我們不能僅僅依賴這一事實,因爲機構有時也會做出不好的投資,就像其他人一樣。當多個機構持有一隻股票時,總是存在他們處於「擁擠交易」的風險。當這樣的交易出現問題時,多個參與方可能會競爭快速出售股票。在沒有增長曆史的公司中,這種風險更高。您可以在下面查看SEP Analytical(上海)歷史的盈利和營業收入,但請記住,故事總是有更多的內容。

big
SZSE:301228 Earnings and Revenue Growth December 20th 2024
深交所:301228 2024年12月20日的收益和營業收入增長

We note that hedge funds don't have a meaningful investment in SEP Analytical (Shanghai). Looking at our data, we can see that the largest shareholder is Shipu (Shanghai) Enterprise Management Co., Ltd. with 45% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.4% and 5.6% of the stock.

我們注意到對SEP Analytical (上海)的對沖基金沒有重大投資。根據我們的數據,最大的股東是Shipu (上海)企業管理有限公司,持有45%的流通股份。相比之下,第二和第三大股東分別持有約7.4%和5.6%的股票。

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

爲了使我們的研究更有趣,我們發現前兩大股東在公司中擁有大多數股權,這意味着他們有足夠的權力影響公司的決策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

雖然研究公司的機構持股能爲您的研究增值,但研究分析師的建議也是一種良好的做法,可以更深入地了解股票的預期表現。我們目前沒有發現任何分析師對該股票的覆蓋,因此該公司不太可能被廣泛持有。

Insider Ownership Of SEP Analytical (Shanghai)

SEP Analytical (上海)的內部持股情況

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

內部人的定義在不同國家之間可能略有不同,但董事會成員始終被算作內部人。管理層最終向董事會負責。然而,管理者成爲執行董事會成員並不罕見,特別是當他們是創始人或首席執行官時。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人擁有股份是一件好事。然而,在某些情況下,這使得其他股東更難讓董事會對決策負責。

Our most recent data indicates that insiders own less than 1% of SEP Analytical (Shanghai) Co., Ltd.. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. It has a market capitalization of just CN¥2.1b, and the board has only CN¥5.8m worth of shares in their own names. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

我們最近的數據表明,內部人士在上海SEP分析有限公司的持股比例不到1%。不過,我們注意到,內部人士可能通過私人公司或其他公司結構間接持有股份。該公司的市值僅爲21億人民幣,而董事會僅以他們自己的名義持有580萬人民幣的股份。許多小型公司的投資者更傾向於看到董事會的投資比例更高。您可以點擊這裏查看這些內部人士是否有買入或賣出。

General Public Ownership

公衆持股

With a 20% ownership, the general public, mostly comprising of individual investors, have some degree of sway over SEP Analytical (Shanghai). While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

公衆持有20%的股份,主要由個人投資者組成,因此在SEP分析(上海)有限公司中有一定的影響力。雖然這一群體不能完全決定公司事務,但確實能夠對公司運行產生真實影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With a stake of 5.6%, private equity firms could influence the SEP Analytical (Shanghai) board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

持有5.6%股份的股權投資公司可能會影響SEP Analytical(上海)的董事會。 有些人可能會喜歡這樣,因爲股權投資有時是監督者,要求管理層負責。但有時,股權投資則是爲了套現,已經將公司上市。

Private Company Ownership

私有公司所有權

We can see that Private Companies own 59%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們可以看到私人公司持有59%的發行股份。這可能值得深入研究。如果相關方,如內部人員,對其中某些私人公司有利益,這應該在年報中披露。私人公司也可能對該公司有戰略利益。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For instance, we've identified 1 warning sign for SEP Analytical (Shanghai) that you should be aware of.

雖然考慮到擁有公司的不同團體是非常重要的,但還有其他更重要的因素。 例如,我們已識別出1個警告信號,關於SEP Analytical(上海),你應該注意。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您也可能會在其他地方找到一個絕佳的投資。請查看這個免費的有趣公司名單。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論